Guangdong Tyran Technology GroupTirzepatide
Ordered Tirzepatide from Guangdong Tyran Technology Group? Mail in a sample (US only) and let us test it.
Test my supplyGuangdong Tyran's tirzepatide profile is thin but clean: identity passed with 99.8% purity and a -2% fill deviation. Sparse test evidence drives prior smoothing; low-trust price data and few reviews add little corroboration.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Guangdong Tyran Technology Group rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 21 Aug 2026 | Pass | jqx4k2p Tested | lab name | View COA | |||
About Guangdong Tyran Technology Group test results from Finnrick
Guangdong Tyran Technology Group is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 7 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Guangdong Tyran Technology Group peptides in this dataset are Retatrutide (6 tests), Tirzepatide (1 test) and CJC-1295 (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 7 recent tests.
Ordered Tirzepatide from Guangdong Tyran Technology Group? Mail in a sample (US only) and let us test it.
Test my supply